Literature DB >> 18590647

[Patent foramen ovale: current state of the art].

Ignacio Cruz-González1, Jorge Solis, Ignacio Inglessis-Azuaje, Igor F Palacios.   

Abstract

Patent foramen ovale is a congenital cardiac lesion that persists into adulthood and which is present in over 25% of the adult population. Its diagnosis, evaluation and treatment have attracted increasing interest as it has been suggested that it may be associated with various pathologic conditions, such as cryptogenic stroke, platypnea-orthodeoxia syndrome, decompression sickness and migraine. However, data on these associations are contradictory. Similarly, the optimum treatment of patients with patent foramen ovale is still debated. This article contains a review of the anatomy, embryology and epidemiology of the condition, its association with other clinical disorders, and current therapeutic options.

Entities:  

Mesh:

Year:  2008        PMID: 18590647

Source DB:  PubMed          Journal:  Rev Esp Cardiol        ISSN: 0300-8932            Impact factor:   4.753


  4 in total

1.  The role of European national journals in education.

Authors:  P Mills; A Timmis; H Ector; P Vardas; G Ambrosio; P Kułakowski; F J Pinto; F Alfonso
Journal:  Neth Heart J       Date:  2010-01       Impact factor: 2.380

2.  [Retrospective case analysis of ophthalmological and systemic risk factors in patients with retinal vascular occlusion].

Authors:  C Klatt; K Purtskhvanidze; H Hasselbach; F Treumer; J Hillenkamp; J Roider
Journal:  Ophthalmologe       Date:  2010-05       Impact factor: 1.059

3.  Transient cortical blindness after intradiscal oxygen-ozone therapy.

Authors:  Agostino Salvatore Vaiano; Cristiana Valente; Giacomo De Benedetti; Guido Caramello
Journal:  Indian J Ophthalmol       Date:  2016-12       Impact factor: 1.848

4.  Patent foramen oval: A rare case of acute ischemia of the upper limb: A case with 2 year follow-up.

Authors:  O Kallel; D Charmake; I Chergui; N El Ouafi; N Ismaili
Journal:  Ann Med Surg (Lond)       Date:  2021-02-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.